BIOADAPTIVES, INC. Stockholders Equity

Quick Answer

BIOADAPTIVES, INC. reported Stockholders Equity of -$1.46 million for fiscal year 2024.

BIOADAPTIVES, INC. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2024 -$1.46M +11.1%
2023 -$1.65M -13.4%
2022 -$1.45M -32.8%
2021 -$1.09M +20.7%
2020 -$1.38M -64.2%
2019 -$839.9K -21.1%
2018 -$693.7K -19692.9%
2017 -$3.5K +98.3%
2015 -$203.4K -173723.9%
2014 -$117.00 -100.1%
2013 $88.5K

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 -$1.47M +18.8% -19.0%
June 30, 2025 -$1.23M +34.1% +21.6%
March 31, 2025 -$1.57M +12.6% -7.3%
December 31, 2024 -$1.46M +11.1% +18.9%
September 30, 2024 -$1.81M -57.6% +3.3%
June 30, 2024 -$1.87M -11.3% -3.9%
March 31, 2024 -$1.80M -10.3% -9.2%
December 31, 2023 -$1.65M -13.4% -43.7%
  • BIOADAPTIVES, INC. showed an increase of +11.1% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2013–2024 period, BIOADAPTIVES, INC.’s stockholders equity has declined by 1754.7% (from $88.5 thousand to -$1.46 million).
  • The most recent figure is from BIOADAPTIVES, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment